KeyBanc upgrades Nike stock rating to Overweight on improving trends

KeyBanc upgraded Nike (NKE) to Overweight with a $90 price target, citing improving trends from the company's 'Win Now' initiatives and confidence in its 'Sport Offense' strategy to drive sustainable growth and margin recovery. This follows Nike's better-than-expected first-quarter results, which have prompted a generally optimistic outlook from multiple analysts, despite acknowledged near-term challenges in areas such as tariffs and the Chinese market.

Analysis

Nike is experiencing a significant positive shift in analyst sentiment, catalyzed by a recent upgrade from KeyBanc to Overweight with a $90 price target. This bullish stance is underpinned by evidence of a successful turnaround, with the firm's 'Win Now' initiatives and 'Sport Offense' strategy expected to drive sustainable growth and margin recovery. This optimism is not isolated; it follows a better-than-expected first quarter that saw North American revenue grow 4% year-over-year. Other firms, including Truist, Piper Sandler, and TD Cowen, have also reiterated Buy ratings and raised price targets, with Piper Sandler noting a sales inflection occurring two quarters ahead of expectations. UBS, while maintaining a Neutral rating, raised its fiscal 2026 and 2027 EPS estimates, signaling underlying fundamental improvement. Despite this chorus of positive revisions, acknowledged headwinds persist, including challenges related to tariffs, digital operations, and performance in the Chinese market. KeyBanc's $90 target is based on a 29.2x multiple on FY2027 EPS estimates, a forward-looking valuation that reflects growing confidence in Nike’s long-term recovery, contrasted with its current P/E ratio of 35.8x.

Key Decisions for Investors

• Given the strong analyst consensus and early signs of a sales inflection, investors may view this as a pivotal moment to re-evaluate Nike's turnaround story and consider accumulating a position before the recovery is fully priced in.
• It is crucial to monitor key risk indicators, particularly performance in the Chinese market and margin developments related to tariffs, as any negative surprises in these areas could challenge the optimistic growth narrative.
• Investors should weigh the improving growth outlook against the stock's current valuation of 35.8x P/E, assessing whether the anticipated margin recovery and strategic initiatives justify this premium relative to more tempered forward-looking multiples.